From a9e0e981785cfdabb28856e6405eb72120a5c8c0 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 11 Mar 2024 10:39:02 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Posts.md | 2 ++ 1 file changed, 2 insertions(+) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index c1791787..f9274b10 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -11,4 +11,6 @@ The clinical trial will have two arms, randomized by school. One arm will receive a single dose of the fixed-dose coformulation tablet (alb 400mg/ivm 9mg for children between 5 and 14 years old, alb 400mg/ivm 18mg for 15-17s), while the other, acting as an active control group, will receive a single dose of albendazole 400mg. + If you want to review the full protocol, please visit the REALISE study's page at clinicaltrials.gov or PACTR. + #+END_VERSE \ No newline at end of file